Skip to NavigationSkip to content

Clinipace appoints Bud Owen and Daryl Porter

Published on: 19/02/10

CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has joined the company as chief technology officer.

Owen will lead the accounting, treasury, and tax group and be a key member of Clinipace’s mergers and acquisitions team.

He initially joined Clinipace as an advisor during the recent acquisition of Worldwide Clinical Research.

Prior to joining Clinipace, Owen served as chief financial officer at a number of large and small companies in the software, web services, and manufacturing industries, including MediaSpan Group, Reichhold Chemicals, and Tables Surfaces, a company he co-founded.

Meanwhile Porter will lead the service engineering, product engineering, and cloud computing infrastructure teams.

Prior to joining Clinipace Worldwide, Porter spent 18 years at Oracle Corporation and held several executive-level positions in both enterprise product development and enterprise support services.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches